Item 7.01. Regulation FD Disclosure.

On June 15, 2023, IIOT-OXYS, Inc., a Nevada corporation (the "Company"), filed a press release which announced the appointment of William D'Agostino to its Advisory Board as a Technical Sales Consultant for his expertise in Biotechnology and Pharmaceutical Continuous Manufacturing Processes.

The furnishing of the press release is not an admission as to the materiality of any information therein. The information contained in the press release is summary information that is intended to be considered in the context of more complete information included in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC") and other public announcements that the Company has made and may make from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures.

The information in this Item 7.01 of this Current Report on Form 8-K and the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the press release shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits.



Exhibit No.   Description
99.1            Press Release dated June 15, 2023
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses